MGA founder and CEO Alex Brill recently appeared on The Hill event Virtually Live to discuss how complex generic medical alternatives can impact and potentially enhance the American healthcare system. In this interview, Brill talks with The Hill moderator Steve Clemons about the MGA report outlining the potential savings from accelerating US approval of complex generics.
“I think its a solid [GDP] number. Obviously the inventory piece creates a little bit of volatility and the investment numbers are a disappointment, but not a surprise. Overall we see a strong consumers. On the Fed, I would agree with Austin. What the Fed has to do now more than ever is try to block out the political noise, focus on the data and make the best call to boost their credibility or sustain their credibility.”
Today, Brill discusses President Trump’s potential appointment options for the Federal Reserve Board of Governors.